Bicycle therapeutics to participate at the 11th annual svb leerink global healthcare conference

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in a fireside chat at the 11th annual svb leerink global healthcare conference on february 16, 2022 at 9:20 a.m. et. the conference will be held in a virtual meeting format. a live webcast of the fireside chat will b
BCYC Ratings Summary
BCYC Quant Ranking